These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9272261)

  • 1. Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?
    Beumont PJ; Russell JD; Touyz SW; Buckley C; Lowinger K; Talbot P; Johnson GF
    Aust N Z J Psychiatry; 1997 Aug; 31(4):514-24. PubMed ID: 9272261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ; Halmi KA; Sarkar NP; Koke SC; Lee JS
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.
    Arnold LM; McElroy SL; Hudson JI; Welge JA; Bennett AJ; Keck PE
    J Clin Psychiatry; 2002 Nov; 63(11):1028-33. PubMed ID: 12444817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group.
    Goldstein DJ; Wilson MG; Thompson VL; Potvin JH; Rampey AH
    Br J Psychiatry; 1995 May; 166(5):660-6. PubMed ID: 7620754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.
    Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S
    Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.
    Arch Gen Psychiatry; 1992 Feb; 49(2):139-47. PubMed ID: 1550466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eating Disorder Examination-Questionnaire as a measure of change in patients with bulimia nervosa.
    Sysko R; Walsh BT; Fairburn CG
    Int J Eat Disord; 2005 Mar; 37(2):100-6. PubMed ID: 15732070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine for bulimia nervosa following poor response to psychotherapy.
    Walsh BT; Agras WS; Devlin MJ; Fairburn CG; Wilson GT; Kahn C; Chally MK
    Am J Psychiatry; 2000 Aug; 157(8):1332-4. PubMed ID: 10910801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.
    Ricca V; Mannucci E; Mezzani B; Moretti S; Di Bernardo M; Bertelli M; Rotella CM; Faravelli C
    Psychother Psychosom; 2001; 70(6):298-306. PubMed ID: 11598429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of bulimia nervosa--experience with fluoxetine.
    Wood A
    Int Clin Psychopharmacol; 1993; 8(4):295-9. PubMed ID: 8277150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
    Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bulimia nervosa in a primary care setting.
    Walsh BT; Fairburn CG; Mickley D; Sysko R; Parides MK
    Am J Psychiatry; 2004 Mar; 161(3):556-61. PubMed ID: 14992983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive therapy, nutritional therapy and their combination in the treatment of bulimia nervosa.
    Hsu LK; Rand W; Sullivan S; Liu DW; Mulliken B; McDonagh B; Kaye WH
    Psychol Med; 2001 Jul; 31(5):871-9. PubMed ID: 11459384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
    Fallon BA; Petkova E; Skritskaya N; Sanchez-Lacay A; Schneier F; Vermes D; Cheng J; Liebowitz MR
    J Clin Psychopharmacol; 2008 Dec; 28(6):638-45. PubMed ID: 19011432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empowerment of women with purging-type bulimia nervosa through nutritional rehabilitation.
    Ventura M; Bauer B
    Eat Weight Disord; 1999 Jun; 4(2):55-62. PubMed ID: 11234243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parotid salivary parameters in bulimic patients - a controlled clinical trial.
    Paszyńska E; Słopień A; Węglarz M; Linden RW
    Psychiatr Pol; 2015; 49(4):709-20. PubMed ID: 26488347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavioral therapy versus combined treatment with group psychoeducation and fluoxetine in bulimic outpatients.
    Ricca V; Mannucci E; Mezzani B; Di Bernardo M; Barciulli E; Moretti S; Cabras PL; Rotella CM
    Eat Weight Disord; 1997 Jun; 2(2):94-9. PubMed ID: 14655848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional interventions for individuals with bulimia nervosa.
    Salvy SJ; McCargar L
    Eat Weight Disord; 2002 Dec; 7(4):258-67. PubMed ID: 12588053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of nutritional management with stress management in the treatment of bulimia nervosa.
    Laessle RG; Beumont PJ; Butow P; Lennerts W; O'Connor M; Pirke KM; Touyz SW; Waadt S
    Br J Psychiatry; 1991 Aug; 159():250-61. PubMed ID: 1773242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring treatment alternatives: weekly dosing of fluoxetine for the continuation phase of major depressive disorder.
    Burke WJ; McArthur-Miller DA
    J Clin Psychiatry; 2001; 62 Suppl 22():38-42. PubMed ID: 11599647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.